Skip to main content
. 2019 Jan 8;6:3. doi: 10.1038/s41439-018-0034-6

Table 1.

Mutations in the RS1 gene and clinical features in patients with congenital retinoschisis

Family no Patient ID Kinship Age Famial/ sporadic Mutation Ocular features
Exon/intron Nucleotide change (NM_000330.3) Amino acid change Novel/ reported (ID) Visual acuity Refraction of spherical equivalent (D) Retinoschisis Electroretinogram Comment
Foveal Peripheral ERG a-amplitude (μV) b/a ratio Light intensity (cds/m2)
1 KS0001 Proband 4mo Sporadic 1 c.35T>C p.Leu12Pro Novel 0.02/NA −0.375/+0.375 −/ +  +/+ 46/38.3 0.61/0.66 30 B) Vx
2 F111 Proband 2 Sporadic 1 c.38T>C p.Leu13Pro rs104894935 NA/NA NA/NA + / +  +/+ NA/NA NA/NA R) VH
3 J0968 Proband 36 Sporadic 1 c.49G>T p.Glu17* Novel 0.8/0.3 + 0.625/−0.375 + / +  −/− 312.5/226 0.78/0.93 3
4 RS30-1 Proband 8 Sporadic 2–3 exon2-3 del Novel 0.3/0.3 + 4/ + 3.625 + / +  + / +  227/167 0.91/0.95 30 L) Vx
5 J0913 Proband 6 Sporadic IVS2 c.78+2T>C USD Novel 0.5/0.7 + 1.125/ + 0.75 + / +  + / +  267.5/NA 0.56/NA 200
6 RS13-1 Proband 4 Familial 3 exon3 del Undetermined 0.4/0.2 + 5.5/ + 2 +/ +  + / +  490/416 1.11/0.97 b L) VH, Vx, B) retinal fold
6 RS13-2 Sibling 11 Familial 3 exon3 del Undetermined 1.2/1.2 + 0.75/ + 0.75 +/ +  −/− NA/NA NA/NA
7 RS14-1 Proband 3 Sporadic 3 c.98G>A p.Trp33* CM141023a 0.6/0.06 + 5.25/ + 6.5 + / +  + /+ 345/274 0.96/1.2 b
8 RS01-1 Proband 16 Familial 3 c.175T>G p.Cys59Gly Novel 0.5/0.02 0/−7.5 + / +  + /+ 467/360 0.55/0.7 3 L) VH
8 RS01-2 Sibling 23 Familial 3 c.175T>G p.Cys59Gly Novel 0.5/0.5 + 0.5/ + 0.5 −/− −/− 314/331 0.3/0.25 3
8 RS01-3 Sibling 20 Familial 3 c.175T>G p.Cys59Gly Novel 0.4/0.4 −0.25/0 + / +  + /+ 375/374 0.58/0.47 3
9 RS11-1 Proband 12 Familial 3 c.175T>G p.Cys59Gly Novel 0.05/0.8 + 2/−0.25 + / +  + /+ 383/403 0.74/0.83 3 R) Retinal hole
9 RS11-2 Sibling 7 Familial 3 c.175T>G p.Cys59Gly Novel 0.4/0.3 + 0.5/−0.25 + / +  −/ +  457/401 0.9/0.76 3
10 J0381 Proband 17 Sporadic 3 c.185_186insT p.Glu62Aspfs*24 Novel 0.3/0.3 −3/−2.5 +/ +  −/− 129/146 1.11/1.16 3
11 J0673 Proband 13 Sporadic 4 c.214G>A p.Glu72Lys rs104894928 0.8/0.7 −2/−2 + / +  + /+ 185/195 0.79/0.76 3
12 J1033 Proband 13 Sporadic 4 c.214G>A p.Glu72Lys rs104894928 0.5/0.9 −1/−0.5 + / +  −/− 229/252 1.31/1.28 3
13 J1062 Proband 32 Sporadic 4 c.214G>A p.Glu72Lys rs104894928 0.5/0.4 −2.375/ + 0.875 + / +  + /+ 119.6/134.3 0.76/0.86 3
14 RS04-1 Proband 16 Familial 4 c.214G>A p.Glu72Lys rs104894928 0.3/0.15 −1.75/−2.5 + / +  + /+ 362/344 0.55/0.67 200
14 RS04-1 Sibling 9 Familial 4 c.214G>A p.Glu72Lys rs104894928 0.7/0.06 −1.25/NA + / +  + /+ NA/NA NA/NA
15 KINKI-113 Proband 50 Sporadic 4 c.214G>A p.Glu72Lys rs104894928 0.2/0.2 −2.75/−1.625 N/N N/N 370/370 0.78/0.8 30
16 NMSCHH011-01 Sibling 42 Familial 4 c.214G>A p.Glu72Lys rs104894928 CF/0.2 NA/ + 0.25 N/ +  N/+ NA/344.5 NA/0.76 10
16 NMSCHH011-02 Proband 47 Familial 4 c.214G>A p.Glu72Lys rs104894928 0.15/0.3 + 0.25/ + 0.75 −/− + /+ 308/243 1.07/1.18 10
17 RS12-1 Proband 3 Sporadic 4 c.218C>T p.Ser73Leu Novel NA/NA NA/NA + / +  −/+ ~0/~0 NA/NA L) retinal degeneration
18 J0256 Proband 18 Sporadic 4 c.266A>G p.Tyr89Cys rs61752060 0.4/0.08 + 0.75/ + 1.5(IOL) + / +  + /+ 250/168 0.72/0.61 3 L) Vx, IOL
19 J1224 Proband 6 Sporadic 4 c.266A>G p.Tyr89Cys rs61752060 0.08/0.5 + 6/ + 6 + / +  + /- NA/NA NA/NA
20 Teik1051 Proband 49 Sporadic 4 c.266A>G p.Tyr89Cys rs61752060 0.1/0.1 + 5/ + 6 −/− + /+ 309.5/137 0.59/0.53 10 L) retinal degeneration
21 Teik1103 Proband 10 Sporadic 4 c.266A>G p.Tyr89Cys rs61752060 0.03/0.6 + 2.75/ + 0.25 + / +  −/− 38.3/35.1 1.25/1.12 3
22 KINKI-107-1 Proband 26 Familial 4 c.267T>A p.Tyr89* rs61752061 0.4/0.3 + 3/ + 2.75 + / +  + /+ 420/400 0.71/0.7 30
22 KINKI-107-2 Sibling 25 Familial 4 c.267T>A p.Tyr89* rs61752061 0.3/0.3 −0.5/−1 + / +  −/− 300/280 1.27/1.29 30
23 RS21-1 Proband 11 Sporadic 4 c.285delG p.Trp96Glyfs*30 Novel 0.2/0.6 −1.5/0.75 + / +  + /+ 503/na 0.75/NA 200 R) Vx
24 RS16-1 Proband 6 Sporadic 4 c.301G>C p.Ala101Pro rs61752066 0.5/0.7 + 0.75/ + 1 + / +  −/− NA/345 NA/0.63 10 B) ODRL
25 RS17-1 Proband 4 Sporadic 4 c.304C>T p.Arg102Trp rs61752067 0.03/0.15 NA/ + 3.125 + / +  + /+ 301/289 0.83/1.06 b
26 RS31-1 Proband 3 Familial 4 c.304C>T p.Arg102Trp rs61752067 0.4/NA + 1.375/NA + / +  + /+ 346/349 0.96/0.96 200 L) Vx
26 RS31-2 Sibling 2mo Familial 4 c.304C>T p.Arg102Trp rs61752067 NA/NA NA/NA + / +  −/− NA/NA NA/NA
27 Teik1153 Proband 45 Sporadic 4 c.304C>T p.Arg102Trp rs61752067 0.032/0.5 + 6/ + 2 1/ +  −/− 146.5/304 0.69/0.62 b
28 J1330 Proband 5 Sporadic 4 c.305G>A p.Arg102Gln rs61752068 0.4/0.4 + 9.5/ + 8 + / +  + /+ 462/607.8 0.79/0.74 200
29 RS23-1 Proband 1 Familial 4 c.305G>A p.Arg102Gln rs61752068 0.7/0.06 + 6.625(IOL)/ + 5(IOL) + / +  + /+ 43.8/43.8 0.55/0.69 200 L) Vx, IOL
29 RS23-2 Sibling 4 Familial 4 c.305G>A p.Arg102Gln rs61752068 0.3/0.12 NA/NA + / +  + /+ NA/NA NA/NA
30 RS08-1 Proband 2 Sporadic 4 c.326G>C p.Gly109Ala Novel 0.2/0.3 + 2.25/ + 2.75 + / +  + /+ 184/208 0.87/0.77 b R) VH, Vx
31 MIYA003-1 proband 16 Familial 4 c.330T>A p.Cys110* rs1801161 0.7/1.2 −0.5/0 + /+ −/− 377.8/302.3 0.78/0.72 3 B) retinal fold, Vx, glaucoma
31 MIYA003-2 Sibling 14 Familial 4 c.330T>A p.Cys110* rs1801161 0.9/0.7 −0.25/ + 0.75 + /+ −/− 87.8/83 0.77/0.74 3
32 RS18-1 Proband 8 Familial 5 c.404G>A p.Gly135Glu Novel 0.4/0.3 + 4.475/ + 4.625 + / +  −/− NA/NA NA/NA
33 J0690 Proband 25 Familial 5 c.417G>T p.Gln139His Novel 0.3/0.4 −0.75/ + 0.25 −/− −/− NA/NA NA/NA B) ODRL
34 J0852 Proband 7 Sporadic 5 c.422G>A p.Arg141His rs61752159 0.7/0.4 + 1.5/ + 1.875 + / +  −/− NA/NA NA/NA
35 MIE52 Proband 53 Familial 5 c.438G>C p.Glu146Asp rs61753163 0.5/0.4 −0.5/0 −/− −/− 270/294 0.81/0.71 30 B) macular degeration
36 J0892 Proband 19 Sporadic IVS5 c.522+1G>A USD rs281865348 0.4/0.3 + 4.25/ + 4.625 + / +  + /+ 172.1/130.6 0.45/0.5 3
37 NHO1025 Proband 54 Sporadic IVS5 c.523-1G>A USD Novel 0.2/0.15 −3.5/−4.125 + / +  −/− 343.25/391.25 0.9/0.93 10
38 RS25-1 Proband 8 Sporadic 6 c.544C>T p.Arg182Cys rs61753171 0.1/1.2 + 2.625/−0.125 + / +  + /+ 283/318 0.74/0.85 200 R) Vx
39 RS26-1 Proband 3mo Sporadic 6 c.544C>T p.Arg182Cys rs61753171 0.5/0.2 + 1(IOL)/−1(IOL) + / +  + /+ 175.5/200.8 0.69/0.64 30 R) Vx IOL
40 RS27-1 Proband 9mo Sporadic 6 c.544C>T p.Arg182Cys rs61753171 0.3/0.3 −0.25/−2.75(aphakia) + / +  + /+ NA/NA NA/NA L) Vx
41 J1461 Proband 38 Sporadic 6 c.544C>T p.Arg182Cys rs61753171 0.4/0.4 −6.5/−7.125 + / +  + /+ 360.5/348.3 0.78/0.68 200
42 KIN Proband 33 Sporadic 6 c.574C>T p.Pro192Ser rs61753174 0.8/0.9 −0.225/−0.25 + / +  −/− 290/280 0.86/0.82 30
43 RS07-1 Proband 16 Sporadic 6 c.589C>T p.Arg197Cys rs281865354 0.1/0.09 + 10/ + 9 −/− + /+ 292/237 1/0.47 200
44 MIE49 Proband 43 Sporadic 6 c.589C>T p.Arg197Cys rs281865354 0.2/0.3 + 2/ + 1.5 + / +  −/− 290/280 0.45/0.5 30
45 RS32-1 Proband 5mo Sporadic 6 c.589C>T p.Arg197Cys rs281865354 Follow/Follow NA/NA + / +  + /+ 257/313 0.95/0.74 200 B) VH, R) Vx
46 RS10-1 Proband 28 Sporadic 6 c.590G>A p.Arg197His rs281865355 0.06/0.08 NA/NA + / +  +/+ NA/NA NA/NA
47 RS19-1 Proband 43 Familial 6 c.598C>T p.Arg200Cys rs281865357 0.2/0.05 + 2.5/ + 2.5 + / +  + /+ 281/355 1.35/0.69 b
48 RS15-1 Proband 6 Sporadic 6 c.599G>A p.Arg200His rs281865358 0.7/0.7 + 0.5/−0.575 + / +  −/− 273.5/248 0.83/0.72 b
49 NTMC218 Prpband 43 Sporadic 6 c.599G>A p.Arg200His rs281865358 0.1/0.1 + 0.25/ + 0.25 + / +  + /+ 268/175.3 0.29/0.86 10 B) Retinal hole
50 RS29-1 Proband 1 Sporadic 6 c.608C>T p.Pro203Leu rs104894930 0.4/NLP NA/NA(aphakia) + / +  + /+ NA/NA NA/NA L) proliferative vitreoretinopathy
51 J0903 Proband 52 Sporadic 6 c.608C>T p.Pro203Leu rs104894930 0.5/0.3 −1.125/−1.25 −/− −/− 174.3/292 0.83/0.77 3 B) macular degeration
52 J0371 Proband 57 Sporadic 6 c.625C>T p.Arg209Cys rs281865361 CF/0.01 NA/0.875 + / +  −/− 114/218 1.25/0.67 3
53 J0640 Proband 31 Sporadic 6 c.625C>A p.Arg209Ser Novel 0.3/1.2 −1/−0.5 + /− −/− 295/279 0.93/0.99 b
54 RS06-1 Proband 49 Sporadic 6 c.638G>A p.Arg213Gln rs281865364 0.15/0.04 −0.5/0 −/− + /+ 312/332 0.77/0.59 b
55 RS05-1 Proband 7 Sporadic 6 c.657C>G p.Cys219Trp CM101549a 0.3/0.3 + 0.25/−0.5 −/− + /+ 344/400 0.69/0.71 b
56 MIYA020-1 proband 9 Familial 6 c.667T>C p.Cys223Arg rs104894929 0.4/0.5 −1/−1.5 + / +  +/+ 436/399.5 0.53/0.52 3 L) retinal fold, Vx
56 MIYA020-2 Sibling 12 Familial 6 c.667T>C p.Cys223Arg rs104894929 0.4/0.4 −1.5/−1 + /+ −/+ 342/382.8 0.55/0.52 3 L) retinal fold, Vx

B both eyes, CF counting finger, L left eye, IOL intraocular lens, mo month-old, NA not available, ODRL Oguchi disease-like retinal reflex, R right eye, USD undetermined splicing defect, VH vitreous hemorrahge, Vx vitrectomy, + present, − absent

aSNP (rs) ID is unavailable and ID of the Human Gene Mutation Database is shown

b20J (data are not interchangable with unit of cds/m2)